Clinical Research Directory
Browse clinical research sites, groups, and studies.
Whole Genome Sequencing in Breast Cancer
Sponsor: Inocras Korea Inc.
Summary
This study aims to conduct whole genome sequencing in breast cancer patients to elucidate individual genetic characteristics and their correlation with breast cancer subtypes. The primary objective is to establish new treatment guidelines aligned with the paradigm shift in precision medicine. The study will include both prospective and retrospective cohorts totaling 1200 participants. Prospective participants must provide consent and be eligible for tissue collection, while retrospective participants must have histologically confirmed breast cancer and available tissue samples from Samsung Medical Center Biobank. The study period spans 3 years for subject enrollment and 5 years for follow-up observations, with an expected completion date of December 31, 2030.
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1200
Start Date
2022-08-02
Completion Date
2030-12-31
Last Updated
2024-04-03
Healthy Volunteers
Not specified
Conditions
Interventions
no intervention needed
no intervention needed
Locations (1)
Samsung Medical Center
Seoul, South Korea